{
    "organizations": [],
    "uuid": "50f7b90f47fed3ab39776aed244c296acf95eace",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ema-says-gilead-pulls-application/brief-ema-says-gilead-pulls-application-to-extend-use-of-zydelig-drug-idUSFWN1QD0TN",
    "ord_in_thread": 0,
    "title": "BRIEF-EMA Says Gilead Pulls Application To Extend Use Of Zydelig Drug ‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - EU MEDICINES AGENCY\n* APPLICATION TO EXTEND USE OF GILEAD SCIENCES ZYDELIG DRUG FOR TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA WITHDRAWN ‍​‍​ Source text for Eikon: ( goo.gl/D3N4P8 ) Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)\n ",
    "published": "2018-02-23T20:25:00.000+02:00",
    "crawled": "2018-02-24T13:27:37.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "eu",
        "medicine",
        "agency",
        "application",
        "extend",
        "use",
        "gilead",
        "science",
        "zydelig",
        "drug",
        "treatment",
        "chronic",
        "lymphocytic",
        "leukaemia",
        "withdrawn",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}